ロード中...
A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis
PURPOSE: FASTR was designed to provide a compact treatment course for high-risk prostate cancer patients but was discontinued because of excess toxicity. We present the results of FASTR-2, which used a lower dose to the prostate (35 Gy vs 40 Gy), smaller posterior PTV margin (4 mm vs 5 mm) and omitt...
保存先:
| 出版年: | Adv Radiat Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6817718/ https://ncbi.nlm.nih.gov/pubmed/31681864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2019.07.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|